NCT02511873View on ClinicalTrials.gov

Fycompa in Subjects With Small Fiber Neuropathy (SFN)

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Neuropathy, Small Fiber
Interventions
DRUG

Fycompa

Subjects will take Fycompa for 6 weeks with a dose range of 2mg to 8mg daily

DRUG

Placebo

Placebo (looks like study drug but has no active ingredients) for 6 weeks with a dose range of 2mg to 8mg daily

Trial Locations (1)

85018

PNA Center for Neurological Research, Phoenix

Sponsors
All Listed Sponsors
collaborator

Eisai Inc.

INDUSTRY

lead

PNA Center for Neurological Research

OTHER